Citius Oncology, Inc. (CTOR)
0.80
+0.01
(+0.98%)
USD |
NASDAQ |
Sep 04, 13:54
Citius Oncology Profit Margin (Quarterly) : -597.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -597.4% |
| March 31, 2026 | -1.60K% |
| Date | Value |
|---|---|
| December 31, 2025 | -140.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -797.9% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -109.0% |
| Return on Assets | -44.69% |
| Return on Invested Capital | -97.29% |
| Gross Profit Margin (Quarterly) | -48.09% |
| Operating Margin (Quarterly) | -583.5% |
| Return on Net Operating Assets | -47.51% |